KMCH

Dr. Prashant Vaijyanath

Dr. Prashant Vaijyanath

MS (PGIMER), MCh (AIIMS, New Delhi), FACS, FCS

Cardiothoracic Surgery , Main Center ,
Call for an Appointment

Dr. Prashant Vaijyanath is a globally renowned Cardiothoracic & Vascular Surgeon with over 30 years of experience. He is widely recognized for pioneering innovations in cardiac surgery, heart transplantation, minimally invasive techniques, and transcatheter valve therapies.

Academic Qualifications

  • MBBS – University of Nagpur
  • MS (General Surgery) – Gold Medal – Postgraduate Institute of Medical Education and Research
  • MCh (Cardiothoracic & Vascular Surgery) – All India Institute of Medical Sciences
  • FACS – Fellow, American College of Surgeons
  • FCS – Rabin Medical Center, Israel

International Fellowships & Academic Exposure

Dr. Prashant has trained and held academic associations with some of the world’s most prestigious institutions, including:

  • Harvard Medical School
  • Cleveland Clinic
  • Tel Aviv University
  • Hadassah Medical Center
  • Peking Union Medical College Hospital
  • Fuwai Hospital
  • University of Leipzig

Landmark Achievements

  • Performed the First Successful Heterotopic Heart Transplant on a Native Beating Heart with Direct Pulmonary Anastomosis in the Asia-Pacific region (2017)
  • Performed the First TAVI (Transcatheter Aortic Valve Implantation) in India (April 2010, Chennai)
  • Performed the First Cardiac Transplant in Western Tamil Nadu (2014)
  • Performed the First Bilateral Sequential Lung Transplant for Eisenmenger Syndrome in India (2015)
  • Performed the First Completely Video-Endoscopic Cardiac Surgery with 3D Vision in India (2015)
  • Introduced Robotic Cardiac Surgery in Western Tamil Nadu (2017)
  • Successfully completed 66+ Heart Transplants

Core Competencies & Areas of Expertise

  • Adult Cardiac Surgery
  • Off-pump Total Arterial Coronary Revascularisation
  • Minimally Invasive Cardiac Surgery (CABG & Valve Procedures)
  • Complex Mitral Valve Reconstruction
  • Aortic Aneurysm & Valve-Sparing Surgery
  • Ross Procedure & Homograft Surgery
  • Redo & High-Risk Cardiac Surgeries
  • Endovascular & Transcatheter Valve Therapies
  • Circulatory Assist Devices & ECMO
  • Cardiac Transplantation
  • Stem Cell Research & Surgical Innovation

His surgical outcomes consistently surpass predicted mortality benchmarks, reflecting exceptional expertise in managing complex and high-risk cases.

Previous Appointments

  • Senior Consultant & Director (Academics), Frontier Lifeline & Dr. K. M. Cherian Heart Foundation, Chennai
  • Senior Consultant & Director (Academics), Asian Heart Institute, Mumbai
  • Faculty & Consultant, All India Institute of Medical Sciences

Professional Memberships

  • Fellow, International Society of Minimally Invasive Cardiac Surgery
  • Fellow, American College of Surgeons
  • Member, Association of Cardiothoracic & Vascular Surgeons of India
  • Member, Pediatric Cardiac Society of India
  • Examiner, National Board of Examinations (CTVS)

Research & Publications

Dr. Prashant has contributed extensively to national and international journals including:

  • Asian Annals of Thoracic & Cardiovascular Surgery
  • Indian Heart Journal
  • Journal of Heart Valve Disease
  • Texas Heart Institute Journal
  • Annals of Cardiac Anaesthesia
  • New England Journal of Medicine (NEJM)

His research interests include transcatheter valve implantation, endovascular grafts, circulatory assist programs, and surgical innovations.

Teaching & Leadership

  • Training Programme Director – Cardiothoracic Surgery
  • Examiner – National Board of Examinations (India)
  • Reviewer for leading international cardiac surgery journals
  • Leader in establishing multiple cardiac centres across India

Commitment to Excellence

Dr. Prashant Vaijyanath is known for combining surgical precision, academic leadership, and innovation. His commitment to advanced cardiac care, transplant excellence, and minimally invasive techniques continues to elevate standards in cardiovascular surgery both nationally and internationally.